Book sale: Save up to 25% on print and eBooks. No promo code needed.
Book sale: Save up to 25% on print and eBooks.
Advances in Clinical Chemistry
1st Edition - April 24, 2015
Editor: Gregory S. Makowski
Hardback ISBN:9780128022658
9 7 8 - 0 - 1 2 - 8 0 2 2 6 5 - 8
eBook ISBN:9780128024645
9 7 8 - 0 - 1 2 - 8 0 2 4 6 4 - 5
Volume 69 in the internationally acclaimed Advances in Clinical Chemistry contains chapters authored by world renowned clinical laboratory scientists, physicians and research… Read more
Purchase Options
LIMITED OFFER
Save 50% on book bundles
Immediately download your ebook while waiting for your print delivery. No promo code is needed.
Volume 69 in the internationally acclaimed Advances in Clinical Chemistry contains chapters authored by world renowned clinical laboratory scientists, physicians and research scientists. The serial provides the latest and most up-to-date technologies related to the field of Clinical Chemistry and is the benchmark for novel analytical approaches in the clinical laboratory.
Expertise of international contributors
Latest cutting-edge technologies
Comprehensive in scope
Clinical Laboratory Professionals, Physicians and Research Scientists
Preface
Chapter One: D-dimer: An Overview of Hemostasis and Fibrinolysis, Assays, and Clinical Applications
Abstract
1 Introduction
2 Overview of Hemostasis
3 Mechanisms of Fibrinolysis
4 Clinical Detection of the Products of Fibrinolysis
5 Clinical Applications of D-dimer
6 Conclusions
Chapter Two: Circulating Biomarkers in Malignant Melanoma
Abstract
1 Some Clinical and Epidemiological Aspects of Melanoma
2 Tumor Biology
3 Circulating Tumor Cells as Biomarkers
4 Circulating Nucleic Acids as Biomarkers
5 Proteins as Tumor Markers
6 Tumor Markers in Guidelines
7 Concluding Remarks
Acknowledgments
Chapter Three: Cancer Therapy and Replication Stress: Forks on the Road to Perdition
Abstract
1 Introduction
2 Eukaryotic DNA Replication
3 DNA-Damaging Agents and Replication Fork Progression
4 The Fates of the Perturbed Forks
5 How Does Replication Inhibition Cause Cell Death?
6 How Is the Replication Stress Response Altered in Cancer?
7 Conclusions
Acknowledgments
Chapter Four: Soluble ST2 in Ventricular Dysfunction
Abstract
1 Introduction
2 Biological Background and Function of ST2
3 sST2 in Experimental Observations
4 ST2 in Clinical Studies
5 Future Perspectives
6 Conclusion
Chapter Five: Biofluid Proteases Profiling in Diabetes Mellitus
Abstract
1 Introduction
2 Proteases in the Pathogenesis of DM and its Related Complications
3 Biofluid Proteases as Biomarkers in Diabetes Mellitus
4 Methods for Screening Proteases and Their Inhibitors in Biofluids
5 Therapeutic Targeting of Proteases in DM
6 Future Directions
Acknowledgments
Chapter Six: Biomarker Characterization by MALDI–TOF/MS
Abstract
1 Introduction
2 Mass Spectrometry for Clinical Diagnosis
3 Applications of MALDI–TOF/MS in Clinical Diagnosis
4 Methods for Improving Detection Efficiency of Disease Biomarkers by MALDI–TOF/MS
5 Conclusions
Acknowledgments
Chapter Seven: Antibody Arrays in Biomarker Discovery
Abstract
1 The Origin of Biomarkers
2 Antibody Array Platforms and Utility
3 Antibody Arrays in Drug Target Discovery
4 Antibody Arrays in Therapeutic Biomarker Discovery
5 Cytokine Antibody Arrays in Asthma Biomarker Discovery
10 Other Diseases Where Antibody Arrays Have Contributed to Biomarker Identification
11 Other Array Technologies
12 Summary
Acknowledgments
Index
No. of pages: 346
Language: English
Published: April 24, 2015
Imprint: Academic Press
Hardback ISBN: 9780128022658
eBook ISBN: 9780128024645
GM
Gregory S. Makowski
Dr Gregory S Makowski is a board certified clinical chemist and fellow of the National Academy of Clinical Biochemistry. Following receipt of his PhD in Biochemistry from the University of Connecticut Storrs, he pursued post-doctoral studies at the University of Connecticut School of Medicine in Farmington that culminated in his joint appointments in the School of Medicine and the Department of Laboratory Medicine at John Dempsey Hospital. He has numerous clinical and basic science publications and serves on various scientific and editorial boards. He is actively engaged in the training of Pathology residents and fellows in the Department of Pathology and Laboratory Medicine at Hartford Hospital. He currently serves as Vice President and Chief Scientific Officer for Clinical Laboratory Partners in Newington CT, USA.
Affiliations and expertise
Vice President and Chief Scientific Officer, Clinical Laboratory Partners, Newington, CT, USA